Research and development for innovative platforms & tests
The Molecular Diagnostic Research Unit (MDRU) is directly partnered with the Department of Pathology’s Division of Genomic Diagnostics, under the leadership of Marylin Li, MD. The MDRU focuses on the research and development of innovative clinical platforms and tests. The MDRU concentrates its efforts on the clinical harnessing of multimodal molecular data generation and analysis of biomarkers for direct clinical application. The MDRU works to develop new methods and workflows to improve and optimize disease prognosis, clinical diagnostic effectiveness and specificity, and patient risk and treatment stratification.
- Clinical diagnostics assessment and implementation
- Research and development to generate new platforms
- Biomarker platform development
- Nexus clinical platform partnership